Cargando…
Immune System Remodelling by Prenatal Betamethasone: Effects on β-Cells and Type 1 Diabetes
Type 1 diabetes (T1D) is a multifactorial disease of unknown aetiology. Studies focusing on environment-related prenatal changes, which might have an influence on the development of T1D, are still missing. Drugs, such as betamethasone, are used during this critical period without exploring possible...
Autores principales: | Perna-Barrull, David, Gieras, Anna, Rodriguez-Fernandez, Silvia, Tolosa, Eva, Vives-Pi, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431597/ https://www.ncbi.nlm.nih.gov/pubmed/32849311 http://dx.doi.org/10.3389/fendo.2020.00540 |
Ejemplares similares
-
Prenatal Betamethasone interferes with immune system development and alters target cells in autoimmune diabetes
por: Perna-Barrull, David, et al.
Publicado: (2019) -
Prenatal Administration of Betamethasone Causes Changes in the T Cell Receptor Repertoire Influencing Development of Autoimmunity
por: Gieras, Anna, et al.
Publicado: (2017) -
Impact of Betamethasone Pretreatment on Engrafment of Cord Blood-Derived Hematopoietic Stem Cells
por: Perna-Barrull, David, et al.
Publicado: (2022) -
Prenatal Betamethasone Exposure and its Impact on Pediatric Type 1 Diabetes Mellitus: A Preliminary Study in a Spanish Cohort
por: Perna-Barrull, David, et al.
Publicado: (2022) -
Repurposed Analog of GLP-1 Ameliorates Hyperglycemia in Type 1 Diabetic Mice Through Pancreatic Cell Reprogramming
por: Villalba, Adrian, et al.
Publicado: (2020)